Hidetaka Matsumoto
16PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Nov 10, 2025
Two-year outcomes of half-fluence photodynamic therapy combined with intravitreal aflibercept for treatment-naïve pachychoroid neovasculopathy.Junki Hoshino, Hidetaka Matsumoto, Saki Numaga
|Jul 10, 2025
Loading phase outcomes of intravitreal aflibercept 8 mg for treatment-naïve neovascular age-related macular degeneration.Hidetaka Matsumoto, Junki Hoshino, Saki Numaga
|Jun 14, 2025
Reduction in choroidal thickness associated with the progression of pachychoroid spectrum diseases.Hidetaka Matsumoto, Junki Hoshino, Kosuke Nakamura
|May 10, 2025
Two-year outcomes of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration.Junki Hoshino, Hidetaka Matsumoto, Saki Numaga
|Jan 23, 2025
Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab.Junki Hoshino, Hidetaka Matsumoto, Kosuke Nakamura
Pageof 3